Published in
Elsevier, Critical Reviews in Oncology/Hematology, (160), p. 103280, 2021
DOI: 10.1016/j.critrevonc.2021.103280
Links
Tools
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
Journal article published in 2021 by
Rosalba Torrisi,
Emilia Marrazzo,
Elisa Agostinetto 
,
Rita De Sanctis ,
Agnese Losurdo,
Giovanna Masci,
Corrado Tinterri,
Armando Santoro
,
Rita De Sanctis ,
Agnese Losurdo,
Giovanna Masci,
Corrado Tinterri,
Armando Santoro
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 